News
09-04-2014, 06:20 AM
Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, has released an update on the clinical trial pipeline for its lead immunotherapy products treating basal cell carcinoma (BCC) and breast cancer.
More... (http://www.news-medical.net/news/20140904/Ascend-Biopharmaceuticals-provides-update-on-clinical-trial-program-for-lead-immunotherapy-products.aspx)
More... (http://www.news-medical.net/news/20140904/Ascend-Biopharmaceuticals-provides-update-on-clinical-trial-program-for-lead-immunotherapy-products.aspx)